Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
69,129.15
(
0.35%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: jq1234 post# 101833

Tuesday, 08/17/2010 3:57:02 PM

Tuesday, August 17, 2010 3:57:02 PM

Post# of 257268
Historical comparisons are misleading for the last few years, because Abraxane revenue slipped when they took the sales in-house away from AZN. Current quarter over last year's quarter, the growth was around 25% ($88m vs $70m), and pre-merger that was about the annual growth rate that analysts were estimating.

Peter
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up